Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 67 Polycystic Ovary Syndrome 3 Neoplasms, Hormone-Dependent 3 Neoplasm Metastasis 2 Carcinoma, Lobular 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Diseases 2 Breast Cancer Female 2 Advanced Breast Cancer 2 Sexuality 1 Sexual Dysfunctions, Psychological 1 Osteoporosis 1 Luminal B/HER2-negative Breast Cancer 1 Leiomyoma 1 Infertility 1 Hot Flashes 1 Hormone Receptor Positive Breast Carcinoma 1 Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer 1 HR+/HER2- Early Breast Cancer 1 HR+/HER2+ Early Breast Cancer 1 Fractures, Bone 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Endometrial Stromal Tumors 1 Endometrial Neoplasms 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Bone Diseases, Metabolic 1

Interventions

Counseling 4 Psychiatric Rehabilitation 3 Sildenafil Citrate 2 methyl N-acetylsibirosaminide 1 exemestane 1 black cohosh root extract 1 Testosterone Propionate 1 Testosterone 1 Tamoxifen 1 Surveys and Questionnaires 1 Sexual Health 1 Radiotherapy 1 Prostatectomy 1 Pilocarpine 1 Phentolamine 1 Papaverine 1 Oncology Nursing 1 Educational Status 1 Diet Therapy 1 Aromatase Inhibitors 1 Arginine 1 ArginMax 1 Alprostadil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sexuality × Aromatase Inhibitors × Clear all

NCT02467686 2017-03-20

Cimicifuga

Irmandade da Santa Casa de Misericordia de Sao Paulo

Phase 4 Unknown

Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon ⚡